CLC number: R392
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 0000-00-00
Cited: 6
Clicked: 6001
CHEN Jian-zhong, ZHU Hai-hong, LIU Ke-zhou, CHEN Zhi. Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant[J]. Journal of Zhejiang University Science A, 2004, 5(4): 467-471.
@article{title="Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant",
author="CHEN Jian-zhong, ZHU Hai-hong, LIU Ke-zhou, CHEN Zhi",
journal="Journal of Zhejiang University Science A",
volume="5",
number="4",
pages="467-471",
year="2004",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.2004.0467"
}
%0 Journal Article
%T Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant
%A CHEN Jian-zhong
%A ZHU Hai-hong
%A LIU Ke-zhou
%A CHEN Zhi
%J Journal of Zhejiang University SCIENCE A
%V 5
%N 4
%P 467-471
%@ 1869-1951
%D 2004
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.2004.0467
TY - JOUR
T1 - Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant
A1 - CHEN Jian-zhong
A1 - ZHU Hai-hong
A1 - LIU Ke-zhou
A1 - CHEN Zhi
J0 - Journal of Zhejiang University Science A
VL - 5
IS - 4
SP - 467
EP - 471
%@ 1869-1951
Y1 - 2004
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.2004.0467
Abstract: Objective: To investigate the effect of interleukin-18 (IL-18) on immune response induced by plasmid encoding hepatitis B virus middle protein antigen and to explore new strategies for prophylactic and therapeutic HBV DNA vaccines. Methods: BALB/c mice were immunized with pCMV-M alone or co-immunized with pcDNA3-18 and pCMV-M and then their sera were collected for analysing anti-HBsAg antibody by ELISA; splenocytes were isolated for detecting specific CTL response and cytokine assay in vitro. Results: The anti-HBs antibody level of mice co-immunized with pcDNA3-18 and pCMV-M was slightly higher than that of mice immunized with pCMV-M alone, but there was not significantly different (P>0.05). Compared with mice injected with pCMV-M,the specific CTL cytotoxity activity of mice immunized with pcDNA3-18 and pCMV-M was significantly enhanced (P<0.05) and the level of IFN-γ in supernatant of splenocytes cultured with HBsAg in vitrowas significantly elevated (P<0.05) while the level of IL-4 had no significant difference (P>0.05). Conclusion: The plasmid encoding IL-18 together with HBV M gene DNA vaccines may enhance specific TH1 cells and CTL cellular immune response induced in mice, so that IL-18 is a promising immune adjuvant.
[1] Babiuk, L.A., Babiul, S.L., Baca-Estrada, M.E., 2002. Novel vaccine strategies.AdvVirus Res,58:29-80.
[2] Beckebaum, S., Cicinnati, V.R., Gerken, G., 2002. DNA-based immunotherapy: potential for treatment of chronic viral hepatitisRev Med Virol,12(5):297-319.
[3] Biet, F., Locht, C., Kremer, L.,2002 Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.J Mol Med,80(3):147-162.
[4] Chen, J.Z., Zhu, H.H., Liu, K.Z., Chen, Z., 2002. Immuneresponse induced in mice by codelivery of IL-18 recombinant and HBV S gene DNA vaccine.Chin J Infect Dis,20(3):156-158 (in Chinese).
[5] Chisari, F.V., Ferrari, C., 1995. Hepatitis B virus immunopathogenesis.Annu Rev Immunol,13:29-60.
[6] Chow, Y.H., Huang, W.L., Chi, W.K., Chu, Y.D., Tao, M.H., 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.J Virol,71(1):169-178.
[7] Chow, Y.H., Chiang, B.L., Lee, Y.L., Chi, W.K., Lin, W.C., Chen, Y.T., Tao, M.H., 1998. Development of Th1 and Th2 populations and the nature of immune response to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.J Immunol,160(3):1320-1329.
[8] Davis, H.L., Mancini, M., Michel, M.L., Whalen, R.G., 1996. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.Vaccine,14(9):910-915.
[9] Franco, A., Guidotti, L.G., Hobbs, M.V., Pasquetto, V., Chisari, F.V., 1997. Pathogenic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice.J Immunol,159(4):2001-2008.
[10] Geissler, M., Tokushige, K., Chante, C.C., Zurawski, V.R. Jr.,Wands, J.R., 1997 Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization.Gastroenterology,112(4):1307-1320.
[11] Geissler, M., Schirmbeck, R., Reimann, J., Blum, H.E., Wands, J.R., 1998. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle and but not the large hepatitis B virus surface antigen in mice.Hepatology,28(1):202-210.
[12] Guidotti, L.G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., Chisari, F.V., 1999 Viral clearance without destruction of infected cells during acute HBV infection.Science,284(5415):825-829
[13] Jung, M.C., Hartmann, B., Gerlach, J.T., Diepolder, H., Gruber, R., Schraut, W., Gruner, N., Zachoval, R., Hoffmann, R., Santantonio, T., Wachtler, M., Pape, G.R.,1999. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.Virology,261(2):165-172.
[14] Krieg, A.M., Davis, H.L., 2001. Enhancing vaccines with immune stimulatory CpG DNA.Curr Opin Mol Ther,3(1):15-24
[15] Leroux-Roels, G., Van, Hecke, E., Michielsen, W., Voet, P., Hauser, P., Petre, J., 1994. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.Vaccine,12(9):812-818.
[16] Livingston, B.D., Alexander, J., Crimi, C., Oseroff, C., Celis, E., Daly, K., Guidotti, L.G., Chisari, F.V., Fikes, J., Chesnut, R.W., Sette, A., 1999. Altered helper T lymphocyte function associated with chronic hepatitisB virus infection and its role in response to therapeutic vaccination in humans.J. Immunol,162(5):3088-3095.
[17] Mancini, M., Hadchouel, M., Davis, H.L., Whalen, R.G., Tiollais, P., Michel, M.L., 1996. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.Proc Natl Acad Sci USA,93(22):12496-12501.
[18] Nakanishi, K., Yoshimoto, T., Tsutsui, H., Okamura, H., 2001. Interleukin-18 regulates both Th1 and Th2 responses.Annu Rev Immunol,19:423-474.
[19] Oka, Y., Akbar, S.M., Horiike, N., Joko, K., Onji, M., 2001. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.Immunology,103(1):90-97.
[20] Rehermann, B., Fowler, P., Sidney, J., Person, J., Redeker, A., Brown, M., Moss, B., Sette, A., Chisari, F.V., 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.J Exp Med,181(3):1047-1058.
[21] Rehermann, B., Lau, D., Hoofnagle, J.H., Chisari, F.V., 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.J Clin Invest,97(7):1655-1665.
[22] Tang, D.C., DeVit, M., Johnston, S.A., 1992. Genetic immunization is a simple method for eliciting an immune response.Nature,356(6365):152-154.
[23] Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A., Felgner, P.L., 1990. Direct gene transfer into mouse muscle in vivo.Science,247(4949 Pt 1):1465-1468 .
[24] Wolff, J.A., Ludtke, J.J., Acsadi, G., Williams, P., Jani, A., 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle.Hum Mol Genet,1(6):363-369.
Open peer comments: Debate/Discuss/Question/Opinion
<1>